drugset / Trial / NCT01837472

Probiotics in the Treatment of Irritable Bowel Syndrome

NCT01837472

Phase 2/3 Completed 132 enrolled Isfahan University of Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Evidence have shown benefits of gut flora modulation in treatment of irritable bowel syndrome (IBS), but few reports are available on the effects of multistrain probiotics and there are few reports available in this regard from our society. Thus, we investigated if probiotics are effective in our patients as well. We hypothesize that the multistrain probiotic Balance containing seven bacteria species including Lactobacillus strains, Bifidobacterium strains, and Streptococcus thermophiles reduces the symptoms of irritable bowel syndrome.

Timeline

Start
2012-04
Primary completion
2013-01
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject ISOXAFLUTOLE Other / unclassified